KROS

62.58

4.39% 2.63

Dopo l'orario di chiusura: 62.58

Keros Therapeutics Inc (KROS)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Perché KROS Giù? Forum Previsione

Precedente Chiudi:

$59.95

Aprire:

$60

Volume 24 ore:

321.45K

Relative Volume:

1.00

Capitalizzazione di mercato:

$2.35B

Reddito:

Utile/perdita netta:

$-168.05M

Rapporto P/E:

-13.78

EPS:

-4.54

Flusso di cassa netto:

$-146.15M

1 W Prestazione:

+4.06%

1M Prestazione:

+2.76%

6M Prestazione:

+3.32%

1 anno Prestazione:

+95.93%

Intervallo 1D:

$59.47

$62.93

Intervallo di 1 settimana:

$57.53

$62.93

Portata 52W:

$27.31

$73.00

Keros Therapeutics Inc Stock (KROS) Company Profile

Nome

Keros Therapeutics Inc

Settore

Healthcare (1182)

Industria

Biotechnology (671)

Telefono

617-314-6297

Indirizzo

1050 WALTHAM STREET, SUITE 302, LEXINGTON, MA

Dipendente

149

Cinguettio

Prossima data di guadagno

2024-11-04

Ultimi documenti SEC

KROS's Discussions on Twitter

Keros Therapeutics Inc Stock (KROS) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2024-02-21	Iniziato	William Blair	Outperform
2023-12-08	Iniziato	Wells Fargo	Overweight
2023-07-31	Iniziato	Wedbush	Outperform
2023-07-26	Iniziato	BofA Securities	Buy
2023-02-14	Iniziato	Cowen	Outperform
2022-10-18	Iniziato	Truist	Buy
2022-07-26	Iniziato	BTIG Research	Buy
2020-12-08	Reiterato	H.C. Wainwright	Buy
2020-05-04	Iniziato	H.C. Wainwright	Buy
2020-05-04	Iniziato	Jefferies	Buy
2020-05-04	Iniziato	Piper Sandler	Overweight
2020-05-04	Iniziato	SVB Leerink	Outperform

Mostra tutto

Keros Therapeutics Inc Borsa (KROS) Ultime notizie

02:16 AM

Keros Therapeutics (NASDAQ:KROS) Now Covered by Jefferies Financial Group - MarketBeat

02:16 AM

11:34 AM

(KROS) Proactive Strategies - Stock Traders Daily

11:34 AM

09:17 AM

Keros Therapeutics to Present at the 66th American Society of Hematology Annual Meeting and Exposition - GlobeNewswire

09:17 AM

05:22 AM

Mirae Asset Global Investments Co. Ltd. Boosts Stock Holdings in Keros Therapeutics, Inc. (NASDAQ:KROS) - Defense World

05:22 AM

Nov 03, 2024

Emerald Advisers LLC Acquires Shares of 155,545 Keros Therapeutics, Inc. (NASDAQ:KROS) - MarketBeat

Nov 03, 2024

Nov 01, 2024

Brokerages Set Keros Therapeutics, Inc. (NASDAQ:KROS) PT at $89.11 - Defense World

Nov 01, 2024

Oct 30, 2024

Keros Therapeutics, Inc. (NASDAQ:KROS) Short Interest Update - MarketBeat

Oct 30, 2024

Oct 29, 2024

Analysts Offer Predictions for KROS FY2024 Earnings - Defense World

Oct 29, 2024

Oct 28, 2024

Assenagon Asset Management S.A. Boosts Position in Keros Therapeutics, Inc. (NASDAQ:KROS) - MarketBeat

Oct 28, 2024

Cantor Fitzgerald Weighs in on KROS FY2024 Earnings - Defense World

Oct 28, 2024

Brokers Set Expectations for KROS FY2024 Earnings - MarketBeat

Oct 28, 2024

Oct 26, 2024

Keros Therapeutics (NASDAQ:KROS) Now Covered by Cantor Fitzgerald - Defense World

Oct 26, 2024

Oct 25, 2024

(KROS) Trading Signals - Stock Traders Daily

Oct 25, 2024

Cantor Fitzgerald initiates coverage on Keros Therapeutics shares with Overweight rating - Investing.com India

Oct 25, 2024

Oct 24, 2024

Cantor Fitzgerald initiates coverage on Keros Therapeutics shares with Overweight rating By Investing.com - Investing.com South Africa

Oct 24, 2024

Cantor Fitzgerald Initiates Coverage on Keros Therapeutics (NASDAQ:KROS) - MarketBeat

Oct 24, 2024

Oct 16, 2024

Keros Therapeutics (NASDAQ:KROS) Now Covered by Scotiabank - MarketBeat

Oct 16, 2024

Keros Therapeutics appoints new Chief Medical Officer - Investing.com

Oct 16, 2024

Keros Therapeutics Appoints Yung H. Chyung, M.D., as Chief Medical Officer - GlobeNewswire

Oct 16, 2024

Keros Therapeutics appoints new Chief Medical Officer By Investing.com - Investing.com UK

Oct 16, 2024

Keros Therapeutics, Inc. Appoints Yung H. Chyung as Chief Medical Officer, Effective as of November 1, 2024 - Marketscreener.com

Oct 16, 2024

Short Interest in Keros Therapeutics, Inc. (NASDAQ:KROS) Declines By 13.7% - MarketBeat

Oct 16, 2024

Oct 15, 2024

Objective long/short (KROS) Report - Stock Traders Daily

Oct 15, 2024

Oct 09, 2024

Renaissance Technologies LLC Invests $654,000 in Keros Therapeutics, Inc. (NASDAQ:KROS) - Defense World

Oct 09, 2024

Renaissance Technologies LLC Acquires New Position in Keros Therapeutics, Inc. (NASDAQ:KROS) - MarketBeat

Oct 09, 2024

Oct 08, 2024

Marshall Wace LLP Has $1.02 Million Holdings in Keros Therapeutics, Inc. (NASDAQ:KROS) - Defense World

Oct 08, 2024

Dimensional Fund Advisors LP Sells 3,691 Shares of Keros Therapeutics, Inc. (NASDAQ:KROS) - Defense World

Oct 08, 2024

Oct 07, 2024

19,832 Shares in Keros Therapeutics, Inc. (NASDAQ:KROS) Bought by Squarepoint Ops LLC - Defense World

Oct 07, 2024

Squarepoint Ops LLC Buys New Shares in Keros Therapeutics, Inc. (NASDAQ:KROS) - MarketBeat

Oct 07, 2024

Oct 04, 2024

Point72 Asia Singapore Pte. Ltd. Buys New Shares in Keros Therapeutics, Inc. (NASDAQ:KROS) - Defense World

Oct 04, 2024

Keros Therapeutics, Inc. (NASDAQ:KROS) Receives $90.63 Consensus PT from Analysts - MarketBeat

Oct 04, 2024

Oct 02, 2024

Understanding the Risks of Investing in Keros Therapeutics Inc (KROS) - Knox Daily

Oct 02, 2024

Oct 01, 2024

Keros Therapeutics completes enrollment for TROPOS trial - Investing.com India

Oct 01, 2024

Leerink Partners sees favorable conditions for Keros Therapeutics shares amid competitive landscape with Winrevair - Investing.com Canada

Oct 01, 2024

Nantahala Capital Management LLC Grows Stock Position in Keros Therapeutics, Inc. (NASDAQ:KROS) - Defense World

Oct 01, 2024

Nantahala Capital Management LLC Acquires 84,810 Shares of Keros Therapeutics, Inc. (NASDAQ:KROS) - MarketBeat

Oct 01, 2024

Point72 Asset Management L.P. Cuts Position in Keros Therapeutics, Inc. (NASDAQ:KROS) - Defense World

Oct 01, 2024

Keros Therapeutics completes enrollment for TROPOS trial By Investing.com - Investing.com South Africa

Oct 01, 2024

Sep 30, 2024

Keros Therapeutics, Inc. (NASDAQ:KROS) Shares Sold by Point72 Asset Management L.P. - MarketBeat

Sep 30, 2024

Sep 29, 2024

Wells Fargo Initiates Coverage of Keros Therapeutics (KROS) with Overweight Recommendation - MSN

Sep 29, 2024

Sep 28, 2024

Point72 Asia Singapore Pte. Ltd. Purchases New Position in Keros Therapeutics, Inc. (NASDAQ:KROS) - Defense World

Sep 28, 2024

Blue Owl Capital Holdings LP Sells 15,000 Shares of Keros Therapeutics, Inc. (NASDAQ:KROS) - MarketBeat

Sep 28, 2024

Fred Alger Management LLC Has $2.24 Million Stock Position in Keros Therapeutics, Inc. (NASDAQ:KROS) - Defense World

Sep 28, 2024

Sep 27, 2024

Iron Deficiency Anemia Market Expected to Experience Major Growth by 2034, According to DelveInsight | Shield Therapeutics, Zeria Pharma, Keros Therapeutics - The Globe and Mail

Sep 27, 2024

Sep 26, 2024

Darwin Global Management Ltd. Boosts Stake in Keros Therapeutics, Inc. (NASDAQ:KROS) - Defense World

Sep 26, 2024

Myelofibrosis Pipeline Forecast 2024: FDA Approvals, Therapies, and Leading Companies by DelveInsight | Galecto Biotech, Lynk Pharma, Samus Therapeutics, Taiga Biotech, Bristol-Myers Squibb, Sumitomo - The Globe and Mail

Sep 26, 2024

17,540 Shares in Keros Therapeutics, Inc. (NASDAQ:KROS) Purchased by Point72 DIFC Ltd - MarketBeat

Sep 26, 2024

Sep 24, 2024